| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DXR | Daxor Common Stock | Award | $0 | +2,000 | +26% | $0.000000 | 9,750 | 31 Oct 2023 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DXR | Stock Options (right to buy) | Award | $0 | +5,000 | $0.000000 | 5,000 | 31 Oct 2023 | COMMON STOCK | 5,000 | $7.99 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Shares granted vest in three (3) equal installments. 666 vest on October 31, 2023; 666 will vest on October 31, 2024; and 668 will vest on October 31, 2025 |
| F2 | Stock options granted on October 31, 2023 are contingent on certain regulatory approvals. |
| F3 | The stock options will vest in three installments. 1,666 vest on October 31, 2023; 1,666 will vest October 31, 2024; and 1,668 will vest on October 31, 2026. |